Clinical Trial Update: Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating immunogenicity and safety of two doses of a live attenuated varicella vaccine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chickenpox

Drugs mentioned

• Live Attenuated Varicella Vaccine (varicella vaccine, live attenuated)

Snippet

Sponsor: Changchun Keygen Biological Products Co., Ltd. | Conditions: Chickenpox | Phase 4 | Status: COMPLETED